Article
The loss of inhibitory C-terminal conformations in disease associated P123H β-synuclein.
Protein science : a publication of the Protein Society - 1 Jan 2016
Janowska Maria K, Baum Jean
Abstract excerpt
β-synuclein (βS) is a homologue of α-synuclein (αS), the major protein component of Lewy bodies in patients with Parkinson's disease. In contrast to αS, βS does not form fibrils, mitigates αS toxicity in vivo and inhibits αS fibril formation in vitro. Previously a missense mutation of βS, P123H, was identified in patients with Dementia with Lewy Body disease. The single P123H mutation at the C-terminus of βS is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
